Huapont Life Science Co (SZSE:002004) Beneish M-Score: -2.74 (As of Sep. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:002004 Huapont Life Science Co Ltd SZSE:002004
65 GF Score
Price ¥4.38
GF Value ¥4.43
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Huapont Life Science Co Beneish M-Score?

Huapont Life Science Co SZSE:002004 -0.23% 65 Beneish M-Score is -2.74 as of Sep. 18, 2026. GuruFocus rates SZSE:002004 with a GF Score™ of 65/100 and a GF Value™ of ¥4.43 (Fairly Valued). The stock has 6 warning signs investors should review. Among 241 Agriculture companies, Huapont Life Science Co ranks better than 73.86% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.74 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Huapont Life Science Co's Beneish M-Score or its related term are showing as below:

SZSE:002004' s Beneish M-Score Range Over the Past 10 Years
Min: -3.07   Med: -2.67   Max: -2.03
Current: -2.74

During the past 13 years, the highest Beneish M-Score of Huapont Life Science Co was -2.03. The lowest was -3.07. And the median was -2.67.


Huapont Life Science Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Huapont Life Science Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Huapont Life Science Co Beneish M-Score Chart

Huapont Life Science Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.35 -2.99 -2.70 -2.49 -2.72

Huapont Life Science Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.83 -2.77 -2.73 -2.74 -2.78

SZSE:002004 vs CTVA, CF, MOS: Beneish M-Score Comparison

For the Agricultural Inputs subindustry, Huapont Life Science Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huapont Life Science Co Beneish M-Score vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Huapont Life Science Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Huapont Life Science Co's Beneish M-Score falls into.


SZSE:002004
65GF Score
Huapont Life Science Co Ltd SZSE:002004
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Huapont Life Science Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Huapont Life Science Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0475+0.528 * 0.893+0.404 * 0.9665+0.892 * 0.9847+0.115 * 0.8963
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0414+4.679 * -0.059784-0.327 * 0.9017
=-2.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Total Receivables was ¥3,642 Mil.
Revenue was 3091.191 + 2818.703 + 2426.359 + 3140.956 = ¥11,477 Mil.
Gross Profit was 1151.904 + 938.219 + 817.548 + 1134.808 = ¥4,042 Mil.
Total Current Assets was ¥11,950 Mil.
Total Assets was ¥29,249 Mil.
Property, Plant and Equipment(Net PPE) was ¥9,475 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥1,198 Mil.
Selling, General, & Admin. Expense(SGA) was ¥2,145 Mil.
Total Current Liabilities was ¥8,577 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3,051 Mil.
Net Income was 131.076 + 145.749 + 79.234 + 258.142 = ¥614 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 485.426 + 230.883 + 1011.357 + 635.171 = ¥2,363 Mil.
Total Receivables was ¥3,531 Mil.
Revenue was 3124.063 + 2789.058 + 2754.833 + 2987.794 = ¥11,656 Mil.
Gross Profit was 1037.776 + 942.886 + 640.341 + 1045.226 = ¥3,666 Mil.
Total Current Assets was ¥11,539 Mil.
Total Assets was ¥29,654 Mil.
Property, Plant and Equipment(Net PPE) was ¥9,908 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥1,108 Mil.
Selling, General, & Admin. Expense(SGA) was ¥2,092 Mil.
Total Current Liabilities was ¥9,380 Mil.
Long-Term Debt & Capital Lease Obligation was ¥3,694 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3642.014 / 11477.208) / (3530.997 / 11655.748)
=0.317326 / 0.30294
=1.0475

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3666.228 / 11655.748) / (4042.479 / 11477.208)
=0.314543 / 0.352218
=0.893

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (11949.833 + 9475.436) / 29249.311) / (1 - (11538.795 + 9908.417) / 29654.478)
=0.267495 / 0.276763
=0.9665

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=11477.208 / 11655.748
=0.9847

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1108.488 / (1108.488 + 9908.417)) / (1198.254 / (1198.254 + 9475.436))
=0.100617 / 0.112262
=0.8963

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2145.35 / 11477.208) / (2092.029 / 11655.748)
=0.186923 / 0.179485
=1.0414

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3051.014 + 8577.353) / 29249.311) / ((3694.163 + 9379.963) / 29654.478)
=0.39756 / 0.440882
=0.9017

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(614.201 - 0 - 2362.836) / 29249.311
=-0.059784

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Huapont Life Science Co has a M-score of -2.79 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.74 mean?
Huapont Life Science Co (SZSE:002004) has a Beneish M-Score of -2.74 as of Sep. 18, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Huapont Life Science Co and its competitors. According to the industry distribution chart, Huapont Life Science Co ranks #63 out of 241 companies in the Agriculture industry, placing it in the top 26.1%.
Is Huapont Life Science Co's Beneish M-Score too high?
Huapont Life Science Co's current Beneish M-Score is -2.74. Based on the distribution chart, Huapont Life Science Co ranks #63 out of 241 companies in the Agriculture industry, which is above the industry midpoint. Overall, Huapont Life Science Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Huapont Life Science Co's Beneish M-Score compare to CTVA and CF?
According to the Agriculture industry distribution chart, Huapont Life Science Co ranks #63 out of 241 companies for Beneish M-Score. This puts Huapont Life Science Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for an Agriculture company?
A good Beneish M-Score depends on the Agriculture industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Huapont Life Science Co and its competitors. Huapont Life Science Co's current Beneish M-Score is -2.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huapont Life Science Co stock overvalued right now?
Based on GuruFocus' analysis, Huapont Life Science Co (SZSE:002004) is currently considered Fairly Valued. The stock's GF Value™ is ¥4.43, compared to a current price of ¥4.38 — trading 1.1% below its estimated fair value. The current Beneish M-Score is -2.74. Huapont Life Science Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Huapont Life Science Co (SZSE:002004), the current Beneish M-Score is -2.74 as of Sep. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Huapont Life Science Co (SZSE:002004) Overvalued in 2026?

Based on GuruFocus' analysis, Huapont Life Science Co stock appears to be undervalued. The current stock price of ¥4.38 is trading 1.1% below its estimated GF Value™ of ¥4.43. GuruFocus considers Huapont Life Science Co to be Fairly Valued.

Key valuation signals for SZSE:002004:

  • Beneish M-Score: -2.74
  • GF Value™: ¥4.43 vs. price of ¥4.38 (1.1% below fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the SZSE:002004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Huapont Life Science Co Business Description

Address No. 69, Renhe Xingguang Avenue, Yubei District, Chongqing, CHN, 401121
Huapont Life Science Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. In addition, the company is also engaged in the agrochemical business and medical business. The agrochemical department is mainly engaged in the research and development, production, sales, and technical services of pesticide intermediates, original drugs, and preparations.
65GF Score

Get the complete analysis for SZSE:002004

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.38
Price
¥4.43
GF Value